跳至主要内容
临床试验/CTRI/2024/02/062577
CTRI/2024/02/062577尚未招募Unknown

Assessment of Atherosclerotic Cardiovascular Disease (ASCVD) Risk using ASCVD Risk Estimator Plus in Indian Patients – A Real-world, Retrospective Study from Electronic Medical Records (HEART-STRONG Study) - HEART-STRONG

Sun Pharma Laboratories Ltd.0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Patients of either sex between 20-79 years of age
  • Patients with SBP between 90-200 mmHg
  • Patients with DBP between 60-130 mmHg
  • Patients with TC between 130-320 mgdL
  • Patients with HDL cholesterol between 20-100 mgdL
  • Patients with data on the history of diabetes (Yes No)
  • Patients with data on smoking status (current former never)
  • Patients with data on hypertension treatment (Yes no)
  • Patients with LDL between 30-300 mgdL
  • Patients with data on statin therapy (Yes No)
  • Patients with data on aspirin therapy (Yes No)

排除标准

  • Patients with current ASCVD and history of ASCVD (i.e. CHD, such as myocardial infarction, angina, and coronary artery stenosis; Cerebrovascular disease, such as a transient ischemic attack, ischemic stroke, and carotid artery stenosis; Peripheral artery disease, such as claudication; Aortic atherosclerotic disease, such as abdominal aortic aneurysm and descending thoracic aneurysm).
  • Patients with incomplete medical records with respect to the required study parameters

研究者

相似试验

A study to assess the cardiovascular disease risk in... | 临床试验